Processa Pharmaceuticals CEO Dr. David Young Issues Letter
HANOVER, MD., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical stage company...
Source: globenewswire.com
Stay updated with breaking news from R David Young. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HANOVER, MD., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical stage company...